{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T11:09:23Z","timestamp":1648897763877},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,10,18]],"date-time":"2012-10-18T00:00:00Z","timestamp":1350518400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s11033-012-2207-6","type":"journal-article","created":{"date-parts":[[2012,10,17]],"date-time":"2012-10-17T16:42:04Z","timestamp":1350492124000},"page":"1591-1597","source":"Crossref","is-referenced-by-count":3,"title":["Two cases with hypereosinophilic syndrome shown with real-time PCR and responding well to imatinib treatment"],"prefix":"10.1007","volume":"40","author":[{"given":"Nur","family":"Selvi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bur\u00e7in Tezcanl\u0131","family":"Kaymaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Handan Haydaro\u011flu","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Pehlivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c7a\u011fda\u015f","family":"Aktan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u015feg\u00fcl","family":"Dalm\u0131zrak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezgi","family":"\u0130nalpolat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Buket","family":"Kosova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahap","family":"Okan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcray","family":"Saydam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,18]]},"reference":[{"issue":"4","key":"2207_CR1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1067\/j.cpradiol.2011.07.015","volume":"41","author":"L Mannelli","year":"2012","unstructured":"Mannelli L, Cherian V, Nayar A, Srichai-Parsia M (2012) Loeffler\u2019s endocarditis in hypereosinophilic syndrome. Curr Probl Diagn Radiol 41(4):146\u2013148","journal-title":"Curr Probl Diagn Radiol"},{"issue":"8","key":"2207_CR2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ajh.22062","volume":"86","author":"J Gotlib","year":"2011","unstructured":"Gotlib J (2011) World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management. Am J Hematol 86(8):677\u2013688","journal-title":"Am J Hematol"},{"issue":"12","key":"2207_CR3","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.2169\/naika.96.2794","volume":"96","author":"A Fujimi","year":"2007","unstructured":"Fujimi A, Kanisawa Y, Kikuchi S, Okuda T, Sato Y, Doi T, Ohta H, Umeda I, Nobuoka A (2007) Identification of clonal proliferation of T cell and FIP1L1-PDGFRalpha fusion gene in hypereosinophilic syndrome associated with lymphomatoid papulosis which showed rapid and complete response to the treatment with imatinib. Nihon Naika Gakkai Zasshi 96(12):2794\u20132797","journal-title":"Nihon Naika Gakkai Zasshi"},{"key":"2207_CR4","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1182\/blood-2002-10-3103","volume":"101","author":"A Pardanani","year":"2003","unstructured":"Pardanani A, Reeder T, Porrata LF, Li CY, Tazelaar HD, Baxter EJ, Witzig TE, Cross NC, Tefferi A (2003) Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders. Blood 101:3391","journal-title":"Blood"},{"issue":"12","key":"2207_CR5","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1182\/blood-2003-01-0081","volume":"101","author":"J Cortes","year":"2003","unstructured":"Cortes J, Ault P, Koller C, Thomas D, Ferrajoli A, Wierda W, Rios MB, Letvak L, Kaled ES, Kantarjian H (2003) Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome. Blood 101(12):4714\u20134716","journal-title":"Blood"},{"issue":"10","key":"2207_CR6","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood.V83.10.2759.2759","volume":"83","author":"PF Weller","year":"1994","unstructured":"Weller PF, Bubley GJ (1994) The idiopathic hypereosinophilic syndrome. Blood 83(10):2759\u20132779","journal-title":"Blood"},{"issue":"1","key":"2207_CR7","first-page":"1","volume":"60","author":"Y Matsuo","year":"2011","unstructured":"Matsuo Y, Inokuma S (2011) Idiopathic hypereosinophilic syndrome (idiopathic HES). Arerugi 60(1):1\u20138","journal-title":"Arerugi"},{"issue":"1","key":"2207_CR8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MOH.0b013e32831c841f","volume":"16","author":"J Sheikh","year":"2009","unstructured":"Sheikh J, Weller PF (2009) Advances in diagnosis and treatment of eosinophilia. Curr Opin Hematol 16(1):3\u20138","journal-title":"Curr Opin Hematol"},{"issue":"12","key":"2207_CR9","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1182\/blood-2003-01-0006","volume":"101","author":"AD Klion","year":"2003","unstructured":"Klion AD, Noel P, Akin C, Law MA, Gilliland DG, Cools J, Metcalfe DD, Nutman TB (2003) Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood 101(12):4660\u20134666","journal-title":"Blood"},{"issue":"13","key":"2207_CR10","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","volume":"348","author":"J Cools","year":"2003","unstructured":"Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J, Kutok J, Clark J, Galinsky I, Griffin JD, Cross NC, Tefferi A, Malone J, Alam R, Schrier SL, Schmid J, Rose M, Vandenberghe P, Verhoef G, Boogaerts M, Wlodarska I, Kantarjian H, Marynen P, Coutre SE, Stone R, Gilliland DG (2003) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348(13):1201\u20131214","journal-title":"N Engl J Med"},{"issue":"2","key":"2207_CR11","first-page":"320","volume":"211","author":"M Frigui","year":"2010","unstructured":"Frigui M, Hmida MB, Jallouli M, Kechaou M, Frikha F, Bahloul Z (2010) Membranous glomerulopathy associated with idiopathic hypereosinophilic syndrome. Saudi J Kidney Dis Transpl 211(2):320\u2013322","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"4","key":"2207_CR12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000013362","volume":"18","author":"YJ Choi","year":"1998","unstructured":"Choi YJ, Lee JD, Yang KH, Woo JY, Kim BK, Bang BK, Shim SI (1998) Immunotactoid glomerulopathy associated with idiopathic hypereosinophilic syndrome. Am J Nephrol 18(4):337\u2013343","journal-title":"Am J Nephrol"},{"key":"2207_CR13","first-page":"477","volume":"58","author":"CP Giudicelli","year":"1998","unstructured":"Giudicelli CP, Didelot F, Duvic C, Desrame J, Herody M, Nedelec G (1998) Eosinophilia and renal pathology. Med Trop (Mars) 58:477\u2013481","journal-title":"Med Trop (Mars)"},{"issue":"2","key":"2207_CR14","first-page":"135","volume":"42","author":"G Garella","year":"1990","unstructured":"Garella G, Marra L (1990) Hypereosinophilic syndrome and renal insufficiency. Minerva Urol Nefrol 42(2):135\u2013136","journal-title":"Minerva Urol Nefrol"},{"issue":"833","key":"2207_CR15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/pgmj.71.833.175","volume":"71","author":"P Richardson","year":"1995","unstructured":"Richardson P, Dickinson G, Nash S, Hoffman L, Steingart R, Germain M (1995) Crescentic glomerulonephritis and eosinophilic interstitial infiltrates in a patient with hypereosinophilic syndrome. Postgrad Med J 71(833):175\u2013178","journal-title":"Postgrad Med J"},{"issue":"4","key":"2207_CR16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0272-6386(88)80227-0","volume":"12","author":"P Hirszel","year":"1998","unstructured":"Hirszel P, Cashell AW, Whelan TV, Dolan R, Yoshihashi A (1998) Urinary Charcot-Leyden crystals in the hypereosinophilic syndrome with acute renal failure. Am J Kidney Dis 12(4):319\u2013322","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2207_CR17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1536\/ihj.52.194","volume":"52","author":"C Wojciechowska","year":"2011","unstructured":"Wojciechowska C, Gala A, Kuczaj A, Jachec W, Foremny A, Helbig G, Wojnicz R, Nowalany-Kozielska E (2011) Heart failure mimicking prior myocardial infarction in a patient with idiopathic hypereosinophilic syndrome. Int Heart J 52(3):194\u2013196","journal-title":"Int Heart J"},{"issue":"5","key":"2207_CR18","first-page":"240","volume":"69","author":"J Oever Ten","year":"2011","unstructured":"Ten Oever J, Theunissen LJ, Tick LW, Verbunt RJ (2011) Cardiac involvement in hypereosinophilic syndrome. Neth J Med 69(5):240\u2013244","journal-title":"Neth J Med"},{"issue":"2","key":"2207_CR19","first-page":"166","volume":"38","author":"CH Chen","year":"2011","unstructured":"Chen CH, Tsai IC, Jan SL, Tsai WL, Chen CC (2011) MDCT evaluation of cardiac involvement in hypereosinophilic syndrome: differentiating mural thrombus, infarcted, and noninfarcted myocardium by delayed-phase scanning. Tex Heart Inst J 38(2):166\u2013169","journal-title":"Tex Heart Inst J"},{"issue":"10","key":"2207_CR20","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s11606-008-0705-y","volume":"23","author":"AA Cincin","year":"2008","unstructured":"Cincin AA, Ozben B, Tanrikulu MA, Baskan O, Agirbasli M (2008) Large apical thrombus in a patient with persistent heart failure and hypereosinophilia: L\u00f6ffler endocarditis. J Gen Intern Med 23(10):1713\u20131718","journal-title":"J Gen Intern Med"},{"issue":"2","key":"2207_CR21","first-page":"236","volume":"89","author":"G Martinelli","year":"2004","unstructured":"Martinelli G, Malagola M, Ottaviani E, Rosti G, Trabacchi E, Baccarani M (2004) Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome. Haematologica 89(2):236\u2013237","journal-title":"Haematologica"},{"issue":"11","key":"2207_CR22","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1182\/blood-2006-10-050054","volume":"109","author":"JV Jovanovic","year":"2007","unstructured":"Jovanovic JV, Score J, Waghorn K, Cilloni D, Gottardi E, Metzgeroth G, Erben P, Popp H, Walz C, Hochhaus A, Roche-Lestienne C, Preudhomme C, Solomon E, Apperley J, Rondoni M, Ottaviani E, Martinelli G, Brito-Babapulle F, Saglio G, Hehlmann R, Cross NC, Reiter A, Grimwade D (2007) Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. Blood 109(11):4635\u20134640","journal-title":"Blood"},{"issue":"9","key":"2207_CR23","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3324\/haematol.11420","volume":"92","author":"M Baccarani","year":"2007","unstructured":"Baccarani M, Cilloni D, Rondoni M, Ottaviani E, Messa F, Merante S, Tiribelli M, Buccisano F, Testoni N, Gottardi E, de Vivo A, Giugliano E, Iacobucci I, Paolini S, Soverini S, Rosti G, Rancati F, Astolfi C, Pane F, Saglio G, Martinelli G (2007) The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study. Haematologica 92(9):1173\u20131179","journal-title":"Haematologica"},{"issue":"4","key":"2207_CR24","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00280-007-0507-7","volume":"61","author":"E Vigna","year":"2008","unstructured":"Vigna E, Lucia E, Gentile M, Mazzone C, Bisconte MG, Gentile C, Armentano A, Ottaviani E, Rondoni M, Martinelli G, Morabito F (2008) PDGFRalpha\/FIP1L1-positive chronic eosinophilic leukemia presenting with retro-orbital localization: efficacy of imatinib treatment. Cancer Chemother Pharmocol 61(4):713\u2013716","journal-title":"Cancer Chemother Pharmocol"},{"issue":"2","key":"2207_CR25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/j.seminhematol.2012.01.001","volume":"49","author":"JH Butterfield","year":"2012","unstructured":"Butterfield JH, Weiter J (2012) Treatment of hypereosinophilic syndromes\u2013the first 100\u00a0years. Semin Hematol 49(2):182\u2013191","journal-title":"Semin Hematol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-012-2207-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-012-2207-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-012-2207-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T21:38:33Z","timestamp":1594762713000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-012-2207-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,18]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["2207"],"URL":"https:\/\/doi.org\/10.1007\/s11033-012-2207-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,18]]}}}